Baseline demographics and clinical characteristics of subjects treated with febuxostat and included in this analysis
| Variable | Treated with febuxostat (n=204) |
| Age, years | 69.1±9.6 |
| Female | 41 (20.1) |
| Systolic blood pressure, mm Hg | 128.8±14.9 |
| Diastolic blood pressure, mm Hg | 73.1±11.8 |
| Body mass index, kg/m2 | 25.0±4.0 |
| Previous history | |
| Hypertension | 179 (87.7) |
| Diabetes mellitus | 77 (37.7) |
| Dyslipidaemia | 122 (59.8) |
| Gouty arthritis | 5 (2.5) |
| Myocardial infarction | 27 (13.2) |
| Stroke | 12 (5.9) |
| Heart failure | 36 (17.6) |
| Medication | |
| Renin–angiotensin system inhibitor | 134 (65.7) |
| Calcium channel blocker | 113 (55.4) |
| Beta-blocker | 75 (36.8) |
| Diuretic | 60 (29.4) |
| Statin | 98 (48.0) |
| Antiplatelet agent | 83 (40.7) |
Data are expressed as mean±SD or number (percentage).